Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats

J. Frank Nash, Bryan Yamamoto

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

A single administration of d-amphetamine and iprindole has been reported to produce selective, long-lasting decreases in brain dopamine (DA) content because of axon terminal degeneration. It has been found that the noncompetitive glutamate (GLU) antagonist, MK 801, blocks d-amphetamine-induced DA depletion in iprindole-treated rats. In the present study, the effect of d-amphetamine (9.2 mg/kg) and iprindole (10 mg/kg) on the extracellular concentrations of DA and GLU was determined in the striatum of awake, freely moving rats by the use of in vivo microdialysis. D-Amphetamine significantly increased DA and GLU efflux in the striatum of iprindole-treated rats as compared to the vehicle-treated group. The increase in the extracellular concentration of GLU occurred 4-6 hr following drug administration. The concentration of DA was decreased significantly in the striatum of d-amphetamine and iprindole-treated rats 7 days following administration as compared to the vehicle-treated group. Inhibition of tyrosine hydroxylase after α-methylparatyrosine (150 mg/kg) administration attenuated d-amphetamine-induced DA and GLU release. The DA antagonist, haloperidol (1 mg/kg), blocked D-amphetamine-induced GLU release without affecting the increase in the extracellular concentration of DA produced by the combination of D-amphetamine and iprindole. Both α-methylparatyrosine and haloperidol blocked the depletion of DA in the striatum 7 days after d-amphetamine and iprindole as compared to the vehicle group. In addition, administration of MK-801 (2 mg/kg) 2 hr after d-amphetamine significantly attenuated the long-term (7 day) decrease in striatal DA content produced by the combination of d-amphetamine and iprindole. These data provide direct evidence that amphetamine increases the extracellular concentration of GLU in iprindole-treated rats. Moreover, these data are suggestive that the acute increase in GLU efflux contributes to the long-term damage to DA axon terminals produced by high dose amphetamine administration.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalBrain Research
Volume627
Issue number1
DOIs
StatePublished - Nov 5 1993
Externally publishedYes

Fingerprint

Iprindole
Amphetamine
Dextroamphetamine
Glutamic Acid
Dopamine
Dizocilpine Maleate
Presynaptic Terminals
Haloperidol
Corpus Striatum
Excitatory Amino Acid Antagonists
Dopamine Antagonists
Microdialysis
Tyrosine 3-Monooxygenase

Keywords

  • d-amphetamine
  • Dopamine
  • Glutamate
  • In vivo microdialysis
  • Iprindole
  • Neurotoxicity

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats. / Frank Nash, J.; Yamamoto, Bryan.

In: Brain Research, Vol. 627, No. 1, 05.11.1993, p. 1-8.

Research output: Contribution to journalArticle

@article{71c49b15543548159c17810043fba842,
title = "Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats",
abstract = "A single administration of d-amphetamine and iprindole has been reported to produce selective, long-lasting decreases in brain dopamine (DA) content because of axon terminal degeneration. It has been found that the noncompetitive glutamate (GLU) antagonist, MK 801, blocks d-amphetamine-induced DA depletion in iprindole-treated rats. In the present study, the effect of d-amphetamine (9.2 mg/kg) and iprindole (10 mg/kg) on the extracellular concentrations of DA and GLU was determined in the striatum of awake, freely moving rats by the use of in vivo microdialysis. D-Amphetamine significantly increased DA and GLU efflux in the striatum of iprindole-treated rats as compared to the vehicle-treated group. The increase in the extracellular concentration of GLU occurred 4-6 hr following drug administration. The concentration of DA was decreased significantly in the striatum of d-amphetamine and iprindole-treated rats 7 days following administration as compared to the vehicle-treated group. Inhibition of tyrosine hydroxylase after α-methylparatyrosine (150 mg/kg) administration attenuated d-amphetamine-induced DA and GLU release. The DA antagonist, haloperidol (1 mg/kg), blocked D-amphetamine-induced GLU release without affecting the increase in the extracellular concentration of DA produced by the combination of D-amphetamine and iprindole. Both α-methylparatyrosine and haloperidol blocked the depletion of DA in the striatum 7 days after d-amphetamine and iprindole as compared to the vehicle group. In addition, administration of MK-801 (2 mg/kg) 2 hr after d-amphetamine significantly attenuated the long-term (7 day) decrease in striatal DA content produced by the combination of d-amphetamine and iprindole. These data provide direct evidence that amphetamine increases the extracellular concentration of GLU in iprindole-treated rats. Moreover, these data are suggestive that the acute increase in GLU efflux contributes to the long-term damage to DA axon terminals produced by high dose amphetamine administration.",
keywords = "d-amphetamine, Dopamine, Glutamate, In vivo microdialysis, Iprindole, Neurotoxicity",
author = "{Frank Nash}, J. and Bryan Yamamoto",
year = "1993",
month = "11",
day = "5",
doi = "10.1016/0006-8993(93)90741-5",
language = "English (US)",
volume = "627",
pages = "1--8",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats

AU - Frank Nash, J.

AU - Yamamoto, Bryan

PY - 1993/11/5

Y1 - 1993/11/5

N2 - A single administration of d-amphetamine and iprindole has been reported to produce selective, long-lasting decreases in brain dopamine (DA) content because of axon terminal degeneration. It has been found that the noncompetitive glutamate (GLU) antagonist, MK 801, blocks d-amphetamine-induced DA depletion in iprindole-treated rats. In the present study, the effect of d-amphetamine (9.2 mg/kg) and iprindole (10 mg/kg) on the extracellular concentrations of DA and GLU was determined in the striatum of awake, freely moving rats by the use of in vivo microdialysis. D-Amphetamine significantly increased DA and GLU efflux in the striatum of iprindole-treated rats as compared to the vehicle-treated group. The increase in the extracellular concentration of GLU occurred 4-6 hr following drug administration. The concentration of DA was decreased significantly in the striatum of d-amphetamine and iprindole-treated rats 7 days following administration as compared to the vehicle-treated group. Inhibition of tyrosine hydroxylase after α-methylparatyrosine (150 mg/kg) administration attenuated d-amphetamine-induced DA and GLU release. The DA antagonist, haloperidol (1 mg/kg), blocked D-amphetamine-induced GLU release without affecting the increase in the extracellular concentration of DA produced by the combination of D-amphetamine and iprindole. Both α-methylparatyrosine and haloperidol blocked the depletion of DA in the striatum 7 days after d-amphetamine and iprindole as compared to the vehicle group. In addition, administration of MK-801 (2 mg/kg) 2 hr after d-amphetamine significantly attenuated the long-term (7 day) decrease in striatal DA content produced by the combination of d-amphetamine and iprindole. These data provide direct evidence that amphetamine increases the extracellular concentration of GLU in iprindole-treated rats. Moreover, these data are suggestive that the acute increase in GLU efflux contributes to the long-term damage to DA axon terminals produced by high dose amphetamine administration.

AB - A single administration of d-amphetamine and iprindole has been reported to produce selective, long-lasting decreases in brain dopamine (DA) content because of axon terminal degeneration. It has been found that the noncompetitive glutamate (GLU) antagonist, MK 801, blocks d-amphetamine-induced DA depletion in iprindole-treated rats. In the present study, the effect of d-amphetamine (9.2 mg/kg) and iprindole (10 mg/kg) on the extracellular concentrations of DA and GLU was determined in the striatum of awake, freely moving rats by the use of in vivo microdialysis. D-Amphetamine significantly increased DA and GLU efflux in the striatum of iprindole-treated rats as compared to the vehicle-treated group. The increase in the extracellular concentration of GLU occurred 4-6 hr following drug administration. The concentration of DA was decreased significantly in the striatum of d-amphetamine and iprindole-treated rats 7 days following administration as compared to the vehicle-treated group. Inhibition of tyrosine hydroxylase after α-methylparatyrosine (150 mg/kg) administration attenuated d-amphetamine-induced DA and GLU release. The DA antagonist, haloperidol (1 mg/kg), blocked D-amphetamine-induced GLU release without affecting the increase in the extracellular concentration of DA produced by the combination of D-amphetamine and iprindole. Both α-methylparatyrosine and haloperidol blocked the depletion of DA in the striatum 7 days after d-amphetamine and iprindole as compared to the vehicle group. In addition, administration of MK-801 (2 mg/kg) 2 hr after d-amphetamine significantly attenuated the long-term (7 day) decrease in striatal DA content produced by the combination of d-amphetamine and iprindole. These data provide direct evidence that amphetamine increases the extracellular concentration of GLU in iprindole-treated rats. Moreover, these data are suggestive that the acute increase in GLU efflux contributes to the long-term damage to DA axon terminals produced by high dose amphetamine administration.

KW - d-amphetamine

KW - Dopamine

KW - Glutamate

KW - In vivo microdialysis

KW - Iprindole

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0027519808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027519808&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(93)90741-5

DO - 10.1016/0006-8993(93)90741-5

M3 - Article

VL - 627

SP - 1

EP - 8

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -